Renalytix (RENX) Competitors

Renalytix (LON:RENX) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability.

Do institutionals & insiders hold more shares of RENX or COG?

28.4% of Renalytix shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 35.7% of Renalytix shares are owned by insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has higher earnings and valuation, RENX or COG?

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Renalytix	£2.29M	5.43	-£33.46M	-£0.24	-31.25
Cambridge Cognition	£13.08M	0.89	-£1.32M	-£0.04	-692.50

Which has more risk and volatility, RENX or COG?

Renalytix has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500.

Does the MarketBeat Community favor RENX or COG?

Cambridge Cognition received 82 more outperform votes than Renalytix when rated by MarketBeat users. However, 74.19% of users gave Renalytix an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

Company	Underperform	Outperform
Renalytix	Outperform Votes 23 74.19%	Underperform Votes 8 25.81%
Cambridge Cognition	Outperform Votes 105 44.30%	Underperform Votes 132 55.70%

Is RENX or COG more profitable?

Renalytix has a net margin of 0.00% compared to Cambridge Cognition's net margin of -10.07%. Cambridge Cognition's return on equity of -74.36% beat Renalytix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Renalytix	N/A	-1,073.18%	-93.54%
Cambridge Cognition	-10.07%	-74.36%	-0.30%

Does the media favor RENX or COG?

In the previous week, Renalytix had 2 more articles in the media than Cambridge Cognition. MarketBeat recorded 3 mentions for Renalytix and 1 mentions for Cambridge Cognition. Renalytix's average media sentiment score of 0.28 beat Cambridge Cognition's score of 0.00 indicating that Renalytix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Renalytix	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cambridge Cognition	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Renalytix beats Cambridge Cognition on 8 of the 15 factors compared between the two stocks.